FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approves Baxter's supplemental application for Cardene IV, an intravenous formulation of nicardipine hydrochloride. The new IV product expands treatment opt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CARDENE IV (nicardipine hydrochloride)

Snippet

SUPPL AP for CARDENE IV (NICARDIPINE HYDROCHLORIDE)